Ferric carboxymaltose increases epoetin-α response and prevents iron deficiency before elective orthopaedic surgery

Br J Anaesth. 2014 Aug;113(2):296-8. doi: 10.1093/bja/aeu245.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Drug Synergism
  • Elective Surgical Procedures
  • Epoetin Alfa
  • Erythropoietin / therapeutic use*
  • Female
  • Ferric Compounds / therapeutic use*
  • Hematinics / therapeutic use*
  • Hemoglobins / metabolism
  • Humans
  • Iron / blood
  • Iron Deficiencies*
  • Male
  • Maltose / analogs & derivatives*
  • Maltose / therapeutic use
  • Middle Aged
  • Orthopedic Procedures / methods*
  • Preoperative Care
  • Recombinant Proteins / therapeutic use

Substances

  • Ferric Compounds
  • Hematinics
  • Hemoglobins
  • Recombinant Proteins
  • Erythropoietin
  • Epoetin Alfa
  • ferric carboxymaltose
  • Maltose
  • Iron